2971 - 2980 of 8825 Results
Title
Year
- Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats2016RESTRICTEDTitle: Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 110Issue #:Start Page: 125End Page: 134Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.07.025Citation Count: 26
- A novel alpha-synuclein G14R missense variant is associated with atypical neuropathological features2025OPENTitle: A novel alpha-synuclein G14R missense variant is associated with atypical neuropathological featuresJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 20Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-025-00889-yBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-025-00889-yCitation Count: 0
-
RESTRICTEDTitle: Discordance Between Balance Ability and Perception Is Associated With Falls in Parkinson’s Disease: A Coordinated AnalysisJournal Name: Neurorehabilitation and Neural RepairPublisher: SAGE PublicationsVol: 39Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/15459683241300456Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11850210/pdf/nihms-2033435.pdfCitation Count: 2
-
OPENTitle: RIC3 variants are not associated with Parkinson's disease in French-Canadians and FrenchJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 53Issue #:Start Page: 194.e9End Page: 194.e11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2017.01.005Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2017.01.005Citation Count: 10
- Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease2021OPENTitle: Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1451End Page: 1455Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.28525Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28525Citation Count: 21
-
OPENTitle: Nicotine‐Mediated Rescue of α‐Synuclein Toxicity Requires Synaptic Vesicle Glycoprotein 2 in DrosophilaJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 2Start Page: 244End Page: 255Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.29283Best OA location URL: https://doi.org/10.1002/mds.29283Citation Count: 28
-
OPENTitle: Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisitedJournal Name: Human Brain MappingPublisher: WileyVol: 37Issue #: 7Start Page: 2547End Page: 2556Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23192Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.23192Citation Count: 78
- Dopaminergic therapy and prefrontal activation during walking in individuals with Parkinson’s disease: does the levodopa overdose hypothesis extend to gait?2020RESTRICTEDTitle: Dopaminergic therapy and prefrontal activation during walking in individuals with Parkinson’s disease: does the levodopa overdose hypothesis extend to gait?Journal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 2Start Page: 658End Page: 668Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-020-10089-xCitation Count: 28
- Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer’s and Parkinson’s disease models of neurodegeneration2018OPENTitle: Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer’s and Parkinson’s disease models of neurodegenerationJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddy308Citation Count: 30
- Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severity2018OPENTitle: Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severityJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 8Start Page: 1315End Page: 1324Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27392Citation Count: 139